These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2544930

  • 1. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides.
    Schmidt WE, Choudhury AR, Siegel EG, Löser C, Conlon JM, Fölsch UR, Creutzfeldt W.
    Regul Pept; 1989 Jan; 24(1):67-79. PubMed ID: 2544930
    [Abstract] [Full Text] [Related]

  • 2. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C, Varga G, Dobronyi I, Papp M.
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat.
    Hajri A, Aprahamian M, Damgé C.
    Digestion; 1989 Mar; 43(1-2):66-72. PubMed ID: 2806757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A, Warzecha Z, Konturek SJ, Banas M, Cai RZ, Schally AV.
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [Abstract] [Full Text] [Related]

  • 7. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D, Rivard N, Maouyo D, Gettys TW, Morisset J.
    Regul Pept; 1993 Feb 18; 43(3):169-76. PubMed ID: 8441822
    [Abstract] [Full Text] [Related]

  • 8. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM, Reidelberger RD, Rosewicz S, Bussjaeger LJ, Solomon TE.
    Regul Pept; 1992 Apr 09; 38(3):207-19. PubMed ID: 1375383
    [Abstract] [Full Text] [Related]

  • 9. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
    Parekh D, Ishizuka J, Townsend CM, Rajaraman S, Thompson JC.
    Ann Surg; 1993 Dec 09; 218(6):735-41. PubMed ID: 8257223
    [Abstract] [Full Text] [Related]

  • 10. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L, Dockray GJ.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):307-11. PubMed ID: 3371402
    [Abstract] [Full Text] [Related]

  • 11. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE, Stöckmann F, Choudhury AR, Wilms HM, Siegel EG, Nustede R, Fölsch UR, Creutzfeldt W.
    Digestion; 1989 Feb 09; 44(2):105-16. PubMed ID: 2612749
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of bombesin-induced pancreatic secretion in unanesthetized rats.
    Liehr RM, Reidelberger RD, Varga G, Solomon TE.
    Peptides; 1993 Feb 09; 14(4):717-23. PubMed ID: 8234015
    [Abstract] [Full Text] [Related]

  • 13. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
    Otsuki M, Fujii M, Nakamura T, Tani S, Oka T, Yajima H, Baba S.
    Am J Physiol; 1987 Apr 09; 252(4 Pt 1):G491-8. PubMed ID: 2436486
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M, Niederau C, Strohmeyer G, Grendell JH.
    Am J Physiol; 1989 Jan 09; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [Abstract] [Full Text] [Related]

  • 15. Influence of repeated administration of bombesin on rat pancreatic secretion.
    Stock-Damgé C, Lhoste E, Aprahamian M, Loza E.
    Pancreas; 1987 Jan 09; 2(6):658-63. PubMed ID: 3438303
    [Abstract] [Full Text] [Related]

  • 16. Effects of bombesin on pancreatic digestive enzyme gene expression.
    Rosewicz S, Liehr RM, Solomon TE, Riecken EO, Logsdon CD.
    Endocrinology; 1992 Mar 09; 130(3):1451-8. PubMed ID: 1371450
    [Abstract] [Full Text] [Related]

  • 17. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
    Wisner JR, Ozawa S, Xue BG, Renner IG.
    Pancreas; 1990 Jul 09; 5(4):434-8. PubMed ID: 1696382
    [Abstract] [Full Text] [Related]

  • 18. [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C antagonizes neuromedin C-stimulated amylase release by acini isolated from the rat pancreas.
    Wisner JR, Xue BG, Coy DH, Renner IG.
    Pancreas; 1990 Jul 09; 5(4):408-14. PubMed ID: 1696379
    [Abstract] [Full Text] [Related]

  • 19. Synthetic neuromedin C stimulates exocrine pancreatic secretion in dogs and rats.
    Hosotani R, Inoue K, Kogire M, Suzuki T, Otsuki M, Rayford PL, Yajima H, Tobe T.
    Pancreas; 1987 Jul 09; 2(4):414-21. PubMed ID: 2442749
    [Abstract] [Full Text] [Related]

  • 20. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
    Vasar E, Harro J, Lang A, Pôld A, Soosaar A.
    Psychopharmacology (Berl); 1991 Jul 09; 105(3):393-9. PubMed ID: 1798834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.